Wednesday - April 15, 2026

Category Archives: Business

Patient Monitoring Devices Market Set for Robust Growth at 10.01% CAGR Through 2032: DelveInsight | Medtronic, GE Healthcare, and Philips Healthcare

Patient Monitoring Devices Market Insights Key global players include Medtronic, GE Healthcare, Philips Healthcare, Abbott Laboratories, Siemens Healthineers, Nihon Kohden Corporation, Masimo Corporation, Omron Healthcare Co., Ltd., Smiths Medical, Hillrom, Welch Allyn, Inc., Natus Medical Incorporated, Mindray Medical International Limited, … Continue reading →

Vascular Closure Devices Market Set for Steady Growth at 5.70% CAGR Through 2032: DelveInsight | Abbott, Teleflex, and Medtronic

Vascular Closure Devices Market Report Key global players include Abbott, Teleflex Incorporated, Terumo Medical Corporation, Cardinal Health, Haemonetics Corporation, Merit Medical Systems, Medtronic, Morris Innovative, BD, TZ Medical, Vasorum Ltd., Tricol Biomedical, Vivasure Medical Ltd., Transluminal Technologies, W. L. Gore … Continue reading →

Transradial Access Products Market to Reach USD 4.1 Billion by 2032, Driven by Rising CVD Prevalence and Demand for Minimally Invasive Procedures: DelveInsight

Transradial Access Products Market Overview The leading companies operating in the transradial access products market include AngioDynamics, Terumo Medical Corporation, Medtronic, and others, who are driving the market through continuous innovation and strategic collaborations. The global transradial access products market … Continue reading →

Metastatic Breast Cancer Clinical Trial Pipeline Expands as 100+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Metastatic Breast Cancer Pipeline Insights 2026” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the metastatic Breast Cancer pipeline landscape. It covers the Metastatic Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

B-Cell Non-Hodgkin Lymphoma Clinical Trial Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “B-Cell Non-Hodgkin Lymphoma Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in B-Cell Non-Hodgkin Lymphoma pipeline landscape. It covers the B-Cell Non-Hodgkin Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Amyotrophic Lateral Sclerosis Clinical Trial Pipeline Shows Potential with Active Contributions from 80+ Key Companies | DelveInsight

DelveInsight’s, “Amyotrophic Lateral Sclerosis Pipeline Insight 2026” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Amyotrophic Lateral Sclerosis pipeline landscape. It covers the Amyotrophic Lateral Sclerosis pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Acute Kidney Injury Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Acute Kidney Injury Pipeline Insight 2026” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Acute Kidney Injury pipeline landscape. It covers the Acute Kidney Injury Pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Advanced Ovarian Cancer Clinical Trial Pipeline Gains Momentum: 10+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Advanced Ovarian Cancer Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Advanced Ovarian Cancer pipeline landscape. It covers the Advanced Ovarian Cancer pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →